Device
Panoptix
Panoptix is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Trials by Status
completed267%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
Clinical Trials (3)
Showing 3 of 3 trials
NCT04124952
Evaluation of Quality of Vision and Spectacle Independence With the AcrySof® Panoptix® Intraocular Lens
NCT04126187
AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study
NCT04545073
Outcomes of a Trifocal IOL in Post-refractive Patients
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3